Search in:

Expert Review of Molecular Diagnostics Volume 16, 2016 - Issue 5

Submit an article Journal homepage

Open access

2,205

Views

CrossRef citations to date

Altmetric

Original Research

A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review

Meta H. M. DiekstraDepartment of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands

Jesse J. SwenDepartment of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands

Hans GelderblomDepartment of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands

Henk-Jan GuchelaarDepartment of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NetherlandsCorrespondence[email protected]

Pages 605-618 | Received 01 Dec 2015, Accepted 27 Jan 2016, Published online: 17 Feb 2016

Cite this article
https://doi.org/10.1586/14737159.2016.1148601
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (18)

Apostolos Papachristos, Jai Patel, Maria Vasileiou & George P. Patrinos. (2023) Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics. Cancers 15:12, pages 3233.
Crossref

Maddalena Centanni, Abel Thijs, Ingrid Desar, Mats O. Karlsson & Lena E. Friberg. (2022) Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors. Clinical and Translational Science 16:1, pages 73-84.
Crossref

Meta H. M. Diekstra, Jesse J. Swen, Loes F. M. van der Zanden, Sita H. Vermeulen, Epie Boven, Ron H. J. Mathijssen, Koya Fukunaga, Taisei Mushiroda, Fumiya Hongo, Egbert Oosterwijk, Anne Cambon-Thomsen, Daniel Castellano, Achim Fritsch, Jesus Garcia Donas, Cristina Rodriguez-Antona, Rob Ruijtenbeek, Marius T. Radu, Tim Eisen, Kerstin Junker, Max Roessler, Ulrich Jaehde, Tsuneharu Miki, Stefan Böhringer, Michiaki Kubo, Lambertus A. L. M. Kiemeney & Henk-Jan Guchelaar. (2022) Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib. Cancers 14:12, pages 2838.
Crossref

Elizabeth A. Burnham, Arsany A. Abouda, Jennifer E. Bissada, Dasean T. Nardone-White, Jessica L. Beers, Jonghwa Lee, Matthew J. Vergne & Klarissa D. Jackson. (2022) Interindividual Variability in Cytochrome P450 3A and 1A Activity Influences Sunitinib Metabolism and Bioactivation. Chemical Research in Toxicology 35:5, pages 792-806.
Crossref

Revati Sharma, Elif Kadife, Mark Myers, George Kannourakis, Prashanth Prithviraj & Nuzhat Ahmed. (2021) Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref

Philip Zeuschner, Angela Zaccagnino & Kerstin Junker. (2021) Biomarker: der Weg zur individualisierten Therapie bei Nierenzelltumoren. Aktuelle Urologie 52:05, pages 452-463.
Crossref

Fengjun Sun, Zhuo Chen, Pu Yao, Bangbi Weng, Zhirui Liu & Lin Cheng. (2021) Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in Pharmacology 12.
Crossref

Darija Kuruc Poje, Nada Božina, Livija Šimičević & Igor Žabić. (2020) Severe hyperglycaemia following pazopanib treatment: The role of drug‐drug‐gene interactions in a patient with metastatic renal cell carcinoma—A case report. Journal of Clinical Pharmacy and Therapeutics 45:4, pages 628-631.
Crossref

Julia Kovacova & Ondrej Slaby. 2019. Tyrosine Kinases as Druggable Targets in Cancer. Tyrosine Kinases as Druggable Targets in Cancer.

Nicola Fazio, Jean-Francois Martini, Adina E Croitoru, Michael Schenker, Sherry Li, Brad Rosbrook, Kathrine Fernandez, Jiri Tomasek, Espen Thiis-Evensen, Matthew Kulke & Eric Raymond. (2019) Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumors. Future Oncology 15:17, pages 1997-2007.
Crossref

Wei Zhuang, Yining Li, Jiabi Chen, Weihui Liu & Hongyuan Huang. (2019) Copper nanocluster-labeled hybridization chain reaction for potentiometric immunoassay of matrix metalloproteinase-7 in acute kidney injury and renal cancer. Analytical Methods 11:19, pages 2597-2604.
Crossref

Daniel J. George, Jean-Francois Martini, Michael Staehler, Robert J. Motzer, Ahmed Magheli, Frede Donskov, Bernard Escudier, Sherry Li, Michelle Casey, Olga Valota, Brigitte Laguerre, Allan J. Pantuck, Hardev S. Pandha, Anup Patel, Maria Lechuga & Alain Ravaud. (2019) Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis. Clinical Cancer Research 25:4, pages 1165-1173.
Crossref

Gracia M. Amaya, Rebecca Durandis, David S. Bourgeois, James A. Perkins, Arsany A. Abouda, Kahari J. Wines, Mohamed Mohamud, Samuel A. Starks, R. Nathan Daniels & Klarissa D. Jackson. (2018) Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib. Chemical Research in Toxicology 31:7, pages 570-584.
Crossref

Megan Li & Deanna L. Kroetz. (2018) Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacology & Therapeutics 182, pages 152-160.
Crossref

Cristina Bianchi, Chiara Meregalli, Silvia Bombelli, Vitalba Di Stefano, Francesco Salerno, Barbara Torsello, Sofia De Marco, Giorgio Bovo, Ingrid Cifola, Eleonora Mangano, Cristina Battaglia, Guido Strada, Giuseppe Lucarelli, Robert H. Weiss & Roberto A. Perego. (2017) The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation. Oncotarget 8:69, pages 113502-113515.
Crossref

Daniela Rodrigues, Márcia Monteiro, Carmen Jerónimo, Rui Henrique, Luís Belo, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2017) Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems. Translational Research 180, pages 1-11.
Crossref

S-A Brown, L Nhola & J Herrmann. (2017) Cardiovascular Toxicities of Small Molecule Tyrosine Kinase Inhibitors: An Opportunity for Systems-Based Approaches. Clinical Pharmacology & Therapeutics 101:1, pages 65-80.
Crossref

Francesca Perrotti, Consuelo Rosa, Ilaria Cicalini, Paolo Sacchetta, Piero Del Boccio, Domenico Genovesi & Damiana Pieragostino. (2016) Advances in Lipidomics for Cancer Biomarkers Discovery. International Journal of Molecular Sciences 17:12, pages 1992.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review

Articles from other publishers (18)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review

Citations (18)

Articles from other publishers (18)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date